[{"NetIncomeLoss_1_Q2_USD":-5083000.0,"ProvisionForDoubtfulAccounts_1_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":1.13,"GeneralAndAdministrativeExpense_2_Q2_USD":7095000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":4329000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":49187285.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":43556107.0,"RepaymentsOfLongTermDebt_2_Q2_USD":1788000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":1957000.0,"OperatingLeasesRentExpenseNet_2_Q2_USD":300000.0,"OperatingLeasesRentExpenseNet_1_Q2_USD":100000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_2_Q2_pure":0.556,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1_Q2_pure":0.3655,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q2_USD":3.6,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_2_Q2_pure":0.0107,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1_Q2_pure":0.0107,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-866000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":763000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":8501658.0,"SellingAndMarketingExpense_1_Q2_USD":14010000.0,"SellingAndMarketingExpense_2_Q2_USD":26158000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":3944000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":7271000.0,"ProvisionForDoubtfulAccounts_2_Q2_USD":-72000.0,"LongTermDebt_0_Q2_USD":29277000.0,"ValuationAllowanceDeferredTaxAssetChangeInAmount_1_Q2_USD":0.0,"ValuationAllowanceDeferredTaxAssetChangeInAmount_2_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q2_shares":863716.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":1375310.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":107610000.0,"StockIssuedDuringPeriodValueNewIssues_2_Q2_USD":107610000.0,"AssetsCurrent_0_Q2_USD":140823000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_0_Q2_USD":30000000.0,"Liabilities_0_Q2_USD":39387000.0,"Cash_0_Q2_USD":196000.0,"InvestmentIncomeNet_2_Q2_USD":7000.0,"Revenues_1_Q2_USD":20654000.0,"Revenues_2_Q2_USD":39361000.0,"NumberOfReportableSegments_2_Q2_Segment":1.0,"OperatingLeasesFutureMinimumPaymentsDueInThreeYears_0_Q2_USD":722000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":0.0,"InvestmentIncomeNet_1_Q2_USD":6000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-1032000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-2062000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-600000.0,"InventoryWriteDown_2_Q2_USD":88000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":3.83,"ResearchAndDevelopmentExpense_1_Q2_USD":2422000.0,"AccountsReceivableNetCurrent_0_Q2_USD":10047000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":193000.0,"DepreciationDepletionAndAmortization_1_Q2_USD":100000.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_2_Q2_USD":101542000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":119621000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":656000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":-7711000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-5122000.0,"OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_0_Q2_USD":439000.0,"PreferredStockDividendRatePercentage_2_Q2_pure":0.08,"DepreciationDepletionAndAmortization_2_Q2_USD":220000.0,"IncreaseDecreaseInInventories_2_Q2_USD":-89000.0,"DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_0_Q2_USD":723000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1_Q2_USD":875000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_2_Q2_USD":1277000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":106585000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.255,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.255,"PaymentsOfStockIssuanceCosts_2_Q2_USD":10600000.0,"OtherAccruedLiabilitiesCurrentAndNoncurrent_0_Q2_USD":525000.0,"Assets_0_Q2_USD":142298000.0,"AccruedRoyaltiesCurrentAndNoncurrent_0_Q2_USD":898000.0,"AccountsPayableCurrent_0_Q2_USD":2921000.0,"LiabilitiesCurrent_0_Q2_USD":9865000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-4177000.0,"LiabilitiesFairValueAdjustment_2_Q2_USD":0.0,"LiabilitiesFairValueAdjustment_1_Q2_USD":0.0,"OperatingLeasesFutureMinimumPaymentsDueInFourYears_0_Q2_USD":744000.0,"InterestExpense_2_Q2_USD":2069000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":2577000.0,"PreferredStockDividendsAndOtherAdjustments_1_Q2_USD":39000.0,"PreferredStockDividendsAndOtherAdjustments_2_Q2_USD":196000.0,"AmortizationOfFinancingCosts_2_Q2_USD":88000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":7873245.0,"InterestPaid_2_Q2_USD":2917000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-4511000.0,"OperatingLeasesFutureMinimumPaymentsDueInTwoYears_0_Q2_USD":897000.0,"DividendsPreferredStock_2_Q2_USD":2500000.0,"InterestExpense_1_Q2_USD":1038000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_2_Q2_pure":0.3557,"NetIncomeLoss_2_Q2_USD":-7515000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":1475000.0,"NumberOfOperatingSegments_2_Q2_Segment":1.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":962633.0,"IssuanceOfStockAndWarrantsForServicesOrClaims_2_Q2_USD":1000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1_Q2_pure":0.0103,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":3512000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_2_Q2_pure":0.0007,"AdditionalPaidInCapital_0_Q2_USD":131734000.0,"GrossProfit_1_Q2_USD":16710000.0,"GrossProfit_2_Q2_USD":32090000.0,"LongTermDebtNoncurrent_0_Q2_USD":29277000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":763000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1_Q2_pure":0.3557,"CashEquivalentsAtCarryingValue_0_Q2_USD":119425000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":4290000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-28868000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":8482634.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":142298000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":0.81,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":10.02,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q2_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"ProceedsFromIssuanceInitialPublicOffering_2_Q2_USD":107610000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":2434000.0,"InventoryNet_0_Q2_USD":7643000.0,"OperatingIncomeLoss_1_Q2_USD":-4051000.0,"OperatingIncomeLoss_2_Q2_USD":-5453000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":2919000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":4.55,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":247244019.0,"ShareBasedCompensation_2_Q2_USD":1277000.0,"AllowanceForDoubtfulAccountsReceivable_0_Q2_USD":300000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":4420030.0,"DerivativeLiabilities_0_Q2_USD":200000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":875000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":271000.0,"DebtInstrumentCarryingAmount_0_Q2_USD":30000000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":866000.0,"StockholdersEquity_0_Q2_USD":102911000.0,"DeferredOfferingCosts_0_Q2_USD":0.0,"ProfitLoss_2_Q2_USD":-7515000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":1277000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.1,"OperatingExpenses_1_Q2_USD":20761000.0,"OperatingExpenses_2_Q2_USD":37543000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":4052000.0,"DerivativeLiabilitiesNoncurrent_0_Q2_USD":245000.0,"DeferredTaxAssetsValuationAllowance_0_Q2_USD":5500000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":10300000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.18,"OperatingLeasesFutureMinimumPaymentsDue_0_Q2_USD":3727000.0,"Ticker":"TMCI","CIK":"1630627","name":"TREACE MEDICAL CONCEPTS, INC.","OfficialName":"Treace Medical Concepts Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1095075841.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20210805"}]